UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000024985 |
|---|---|
| Receipt number | R000028190 |
| Scientific Title | Discontinuation study of nilotinib in patients with chronic myeloid leukemia who have maintained complete molecular remission for at least 2 years: the prospective, multicenter stop study in Japan adult leukemia study group |
| Date of disclosure of the study information | 2016/11/24 |
| Last modified on | 2022/11/29 11:48:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/11/24 22:25:49 | ||
| 2 | Update | 2016/11/24 22:30:01 | Recruitment status |
|
| 3 | Update | 2017/05/25 14:24:37 | Recruitment status |
|
| 4 | Update | 2020/11/30 14:58:51 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
| 5 | Update | 2021/05/31 08:46:04 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Division name Division name Address Address Organization Organization Address Address Tel |
|
| 6 | Update | 2021/05/31 08:48:20 | Number of participants that the trial has enrolled |
|
| 7 | Update | 2022/11/29 11:23:33 | Address TEL |
|
| 8 | Update | 2022/11/29 11:48:41 | Last follow-up date |
